Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
154 | 3 | NEUROSCIENCES//HYPERALGESIA//OPIOID RECEPTORS | 64165 |
1161 | 2 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ | 9812 |
24798 | 1 | OHMEFENTANYL//C 11DIPRENORPHINE//C 11CARFENTANIL | 324 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | OHMEFENTANYL | authKW | 607952 | 3% | 63% | 10 |
2 | C 11DIPRENORPHINE | authKW | 405305 | 2% | 83% | 5 |
3 | C 11CARFENTANIL | authKW | 397194 | 2% | 58% | 7 |
4 | H 3OHMEFENTANYL | authKW | 291821 | 1% | 100% | 3 |
5 | DIPRENORPHINE | authKW | 255968 | 3% | 26% | 10 |
6 | ABX ADV BIOCHEM CPDS | address | 222336 | 1% | 57% | 4 |
7 | FENTANYL ANALOGS | authKW | 172926 | 1% | 44% | 4 |
8 | CARFENTANIL | authKW | 131304 | 3% | 15% | 9 |
9 | 4 ANILIDOPIPERIDINES | authKW | 129697 | 1% | 67% | 2 |
10 | USTAV OCHRANY PROTI ZBRANIM HROMADNEHO NICENI | address | 129697 | 1% | 67% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 1087 | 18% | 0% | 57 |
2 | Pharmacology & Pharmacy | 683 | 28% | 0% | 91 |
3 | Neurosciences | 342 | 21% | 0% | 67 |
4 | Radiology, Nuclear Medicine & Medical Imaging | 326 | 13% | 0% | 43 |
5 | Chemistry, Multidisciplinary | 211 | 19% | 0% | 61 |
6 | Chemistry, Organic | 113 | 10% | 0% | 32 |
7 | Neuroimaging | 85 | 2% | 0% | 7 |
8 | Biochemical Research Methods | 81 | 6% | 0% | 20 |
9 | Anesthesiology | 53 | 3% | 0% | 9 |
10 | Psychiatry | 36 | 5% | 0% | 16 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ABX ADV BIOCHEM CPDS | 222336 | 1% | 57% | 4 |
2 | USTAV OCHRANY PROTI ZBRANIM HROMADNEHO NICENI | 129697 | 1% | 67% | 2 |
3 | AFFECT RISK GAMBLING EXPERIMENTS | 97274 | 0% | 100% | 1 |
4 | CHEM MED CHEM SECTBLDG 4ROOM 135 | 97274 | 0% | 100% | 1 |
5 | CIVIL BIOMED ENGN | 97274 | 0% | 100% | 1 |
6 | DIGITAL MEDIA COMMONS MLIBRARY | 97274 | 0% | 100% | 1 |
7 | EQUIPE ACCUEIL TRACEURS TRAITEMENT IMAGE 3033 | 97274 | 0% | 100% | 1 |
8 | FR 1744 CNRS | 97274 | 0% | 100% | 1 |
9 | GRP DEV METHODOL TOMOGR H EMISS POSITONS | 97274 | 0% | 100% | 1 |
10 | GUANGHZOU CHEM | 97274 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ACTA PHARMACOLOGICA SINICA | 6798 | 6% | 0% | 20 |
2 | NUCLEAR MEDICINE AND BIOLOGY | 3743 | 4% | 0% | 12 |
3 | JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 3648 | 4% | 0% | 13 |
4 | ELECTRONIC JOURNAL OF THEORETICAL CHEMISTRY | 1869 | 0% | 2% | 1 |
5 | JOURNAL OF MEDICINAL CHEMISTRY | 1588 | 6% | 0% | 19 |
6 | JOURNAL OF THE SERBIAN CHEMICAL SOCIETY | 1404 | 2% | 0% | 6 |
7 | SEMINARS IN NEUROSCIENCE | 1388 | 0% | 1% | 1 |
8 | KHIMIKO-FARMATSEVTICHESKII ZHURNAL | 1356 | 2% | 0% | 6 |
9 | ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | 1077 | 1% | 1% | 2 |
10 | SYNAPSE | 1046 | 2% | 0% | 6 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OHMEFENTANYL | 607952 | 3% | 63% | 10 | Search OHMEFENTANYL | Search OHMEFENTANYL |
2 | C 11DIPRENORPHINE | 405305 | 2% | 83% | 5 | Search C+11DIPRENORPHINE | Search C+11DIPRENORPHINE |
3 | C 11CARFENTANIL | 397194 | 2% | 58% | 7 | Search C+11CARFENTANIL | Search C+11CARFENTANIL |
4 | H 3OHMEFENTANYL | 291821 | 1% | 100% | 3 | Search H+3OHMEFENTANYL | Search H+3OHMEFENTANYL |
5 | DIPRENORPHINE | 255968 | 3% | 26% | 10 | Search DIPRENORPHINE | Search DIPRENORPHINE |
6 | FENTANYL ANALOGS | 172926 | 1% | 44% | 4 | Search FENTANYL+ANALOGS | Search FENTANYL+ANALOGS |
7 | CARFENTANIL | 131304 | 3% | 15% | 9 | Search CARFENTANIL | Search CARFENTANIL |
8 | 4 ANILIDOPIPERIDINES | 129697 | 1% | 67% | 2 | Search 4+ANILIDOPIPERIDINES | Search 4+ANILIDOPIPERIDINES |
9 | 11CCARFENTANIL | 97274 | 0% | 100% | 1 | Search 11CCARFENTANIL | Search 11CCARFENTANIL |
10 | 2 2 DIAZOLYLAZOPHENOL MOIETY | 97274 | 0% | 100% | 1 | Search 2+2+DIAZOLYLAZOPHENOL+MOIETY | Search 2+2+DIAZOLYLAZOPHENOL+MOIETY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |